Covid: Dr Reddy's eyes Sputnik vaccine exports after domestic struggle

Now, Dr Reddy's is focusing on the single-dose Sputnik Light, as a booster shot or standalone, instead of the two-dose Sputnik V, a spokesperson said

India is the leading production hub for production of Sputnik vaccine

India's Dr. Reddy's Laboratories is in talks with partners to export domestically made doses of Russia's COVID-19 vaccine, Sputnik, after New Delhi recently approved shipments of other shots, the firm said on Monday.

As the main Indian distributor of Sputnik, sold only on the private market, Dr. Reddy's has struggled to compete with vaccines that the government distributes free.

It makes up barely 1 million of a national total of 1.2 billion administered doses, while the AstraZeneca vaccine produced by the Serum Institute of India accounts for nearly 90% of that figure, followed by home-grown Covaxin.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Nov 29 2021 | 5:41 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to